The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII)

Cell Death and Differentiation

Volumn 19, Issue 10, 2012, Pages 1698-1708

  Nascimbeni, A C ^a   Fanin, M ^a   Masiero, E ^b   Angelini, C ^a,c   Sandri, M ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Atrophy; autophagy; glycogen storage disease; MuRF1; Pompe disease

Indexed keywords

GLUCOSIDASE; PROTEIN P62;

ADULT; ARTICLE; AUTOPHAGY; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; ENZYME REACTIVATION; FEMALE; GENE EXPRESSION; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFANT; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE WEAKNESS; MYOTUBE; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ALPHA-GLUCOSIDASES; AUTOPHAGY; CHILD; ENZYME REPLACEMENT THERAPY; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN BINDING; RECOMBINANT PROTEINS; RNA-BINDING PROTEINS;

EID: 84866082112     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2012.52     Document Type: Article

References (21)

1. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075. (Pubitemid 351317450)
2. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007; 6: 458-471. (Pubitemid 350163055)
3. Engel AG, Hirschhorn R, Huie ML. Acid maltase deficiency. In: Engel AG, Franzini-Armstrong C (eds). Myology. McGraw-Hill Press: New York, 2004, pp 1559-1586.
4. Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 2000; 406: 906-910. (Pubitemid 30664268)
5. Kalimo H, Savontaus ML, Lang H, Paljärvi L, Sonninen V, Dean PB et al. X-linked myopathy with excessive autophagy: a new hereditary muscle disease. Ann Neurol 1988; 23: 258-265. (Pubitemid 18086154)
6. Ramachandran N, Munteanu I, Wang P, Aubourg P, Rilstone JJ, Israelian N et al. VMA21 deficiency causes an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification. Cell 2009; 137: 235-246.
7. Stauber WT, Hedge AM, Trout JJ, Schottelius BA. Inhibition of lysosomal function in red and white skeletal muscles by chloroquine. Exp Neurol 1981; 71: 295-306. (Pubitemid 11179628)
8. Raben N, Takikita S, Pittis MG, Bembi B, Marie SK, Roberts A et al. Deconstructing Pompe disease by analyzing single muscle fibers: to see a world in a grain of sand. Autophagy 2007; 3: 546-552. (Pubitemid 350060050)
9. Raben N, Baum R, Schreiner C, Takikita S, Mizushima N, Ralston E et al. When more is less: excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease. Autophagy 2009; 5: 111-113.
10. Raben N, Schreiner C, Baum R, Takikita S, Xu S, Xie T et al. Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder-murine Pompe disease. Autophagy 2010; 6: 1078-1089.
11. Raben N, Hill V, Shea L, Takikita S, Baum R, Mizushima N et al. Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. Hum Mol Genet 2008; 17: 3897-3908. (Pubitemid 352762852)
12. Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M et al. Autophagy is required to maintain muscle mass. Cell Metab 2009; 10: 507-515.
13. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004; 18: 39-51. (Pubitemid 38076464)
14. Nascimbeni AC, Fanin M, Tasca E, Angelini C. Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency. Neurology 2008; 70: 617-626. (Pubitemid 351294639)
15. Chien YH, Lee NC, Thurberg BL, Chiang SC, Zhang XK, Keutzer J et al. Pompe disease in infants: improving the prognosis by newborn screening and early treatment. Pediatrics 2009; 124: e1116-e1125.
16. Takikita S, Schreiner C, Baum R, Xie T, Ralston E, Plotz PH et al. Fiber type conversion by PGC-1a activates lysosomal and autophagosomal biogenesis in both unaffected and Pompe skeletal muscle. PLoS One 2010; 5: e15239.
17. Salminen A, Kaarniranta K. Regulation of the aging process by autophagy. Trends Mol Med 2009; 15: 217-224.
18. Takikita S, Myerowitz R, Schreiner C, Baum R, Raben N, Plotz PH. The values and limits of an in vitro model of Pompe disease: the best laid schemes o' mice an' men. Autophagy 2009; 5: 729-731.
19. Sandri M, Sandri C, Gilbert A, Skurk C. Calabria E, Picard A et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117: 399-412. (Pubitemid 38534545)
20. Léger B, Vergani L, Sorarù G, Hespel P, Derave W, Gobelet C et al. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB 2006; 20: 583-585. (Pubitemid 46671257)
21. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3 (research0034). 1-11.